Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Endometrial, Gynecologic
Status:
Closed
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Eligible for screening study DCP 001
GY020 is closed to accrual, effective August 29, 2022
NCT#04214067
